Cipla partners with TEACH to create career opportunities for hearing-impaired youth
The company also organised sensitization workshops for its employees aimed at increasing awareness of challenges faced by hearing-impaired individuals
The company also organised sensitization workshops for its employees aimed at increasing awareness of challenges faced by hearing-impaired individuals
Commenced operations in flood-affected Himachal Pradesh
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
Cipla has reported total income of Rs. 6465.18 crores during the period ended June 30, 2023
Cipla has a robust governance model focused on sustainability
Cipla has reported total income of Rs. 5873.93 crores during the period ended March 31, 2023
Galvus has the potential to contribute significantly to Cipla’s portfolio in the diabetes care continuum space with reported sales of Rs. 268 crore
Point-of-Care solution to facilitate clinicians in quick and effective decision making
Cipla and Ethris partner for the development of mRNA-based therapies
Leuprolide Acetate Injection Depot contains 22.5 mg of leuprolide acetate for 3- month administration given as a single dose injection.
Subscribe To Our Newsletter & Stay Updated